Using a new technique to deliver gene-therapy-like intervention directly where it's needed, a research team at Thomas Jefferson University successfully increased or decreased the muscle tone of the anal sphincter in appropriate animal models. These studies could have implications in treating constipation or incontinence. The study is published in the American Journal of Physiology-Gastrointestinal and Liver Physiology.
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.
Both constipation and incontinence, although multifactorial, have also been associated with the problems related to the regulation of a ring of smooth muscle around the anal opening termed, the internal anal sphincter. Unlike the way we can clench muscles just by thinking about them, smooth muscle is a type of muscle that we can't control with our thoughts. Dr. Satish Rattan, Professor in the Department of Medicine, Division of Gastroenterology and Hepatology at Jefferson's Sidney Kimmel Medical College, together with Drs. Jagmohan Singh and Ipsita Mohanty, used altered copies of the body's own genetic make-up - small RNA fragments (microRNAs) that regulate the target gene RhoA/ROCK - in order to strengthen or weaken the muscle tone of the sphincter. (Dr. Rattan's lab had shown earlier that changing RhoA/ROCK gene expression could alter smooth muscle tone.) But rather than simply inject the agent, where it could have spread through the tissue to affect other regions, the investigators kept the microRNAs localized to the ring of muscle. They did this by first injecting the microRNAs mixed with micro metal beads, and then kept them localized to the sphincter with a magnet. This innovative yet simple approach was more effective at keeping the microRNAs in the right place than injecting the microRNAs alone.